REGENXBIO Inc.
RGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$227 | -$263 | -$280 | $128 |
| Dep. & Amort. | $16 | $17 | $13 | $10 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $38 | $40 | $41 | $39 |
| Change in WC | $6 | -$11 | $14 | $40 |
| Other Non-Cash | -$6 | -$2 | $5 | $4 |
| Operating Cash Flow | -$173 | -$218 | -$207 | $219 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$10 | -$31 | -$84 |
| Net Acquisitions | $0 | $0 | $0 | -$5 |
| Inv. Purchases | -$190 | -$87 | -$185 | -$498 |
| Inv. Sales/Matur. | $290 | $287 | $204 | $176 |
| Other Inv. Act. | $6 | $0 | $0 | $5 |
| Investing Cash Flow | $103 | $191 | -$12 | -$407 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $131 | $7 | $2 | $218 |
| Stock Repurch. | $1 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$40 | -$42 | -$31 | -$23 |
| Financing Cash Flow | $93 | -$35 | -$29 | $195 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $23 | -$62 | -$248 | $7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $99 | $347 | $340 |
| End Cash | $60 | $37 | $99 | $347 |
| Free Cash Flow | -$176 | -$228 | -$238 | $135 |